A common molecular feature identified is the increased BCR signaling in a significant fraction of DLBCL patients, ABC-DLBCL by cell-of-origin scheme and BCR-DLBCL by consensus clustering scheme. The gene discussed is BCR; the disease is aneurysmal bone cyst.